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Introduction.
Schizophrenia (SCZ) is a devastating psychiatric disorder with an estimated lifetime prevalence of 0.55% worldwide (1). With heritability of about 81% (2), genetics plays a critical role in the disease's etiology, however the mechanism by which genetic variation contributes to the disease is unknown. Many direct and indirect pieces of evidence indicate that aberrations in excluded controls that endorsed either MDD probe question on the GPC screener (10), effectively removing individuals with a potential history of MDD.
Cell culture and transcriptome sequencing
We developed cell cultures from olfactory biopsies (12) as described previously (9).
In brief, each biopsy sample was dissected into pieces approximately 1mm3 in size, placed on the surface of a 60mm tissue culture dish coated by Matrigel basement membrane (MBM) (BD Bioscience, San Jose, California, USA) reconstituted in Coon's medium (1:2), and then every piece of tissue sample was covered by a droplet of full-strength MBM. After MBM gelatinizes, 5 ml of medium 4506 (Ghanbari et al., 2004) was added. Within 1-4 weeks of culturing, CNON cells were observed to grow out of the embedded pieces of tissue. Due to unique ability to grow through Matrigel, neural progenitors often populate large areas without presence of other cell types (supplemental Figure S1 ). Outgrown cells with a neuronal phenotype were then physically isolated using cloning cylinders and dislodged using Dispase (BD Bioscience). Cells collected from inside the cloning cylinders were further grown on tissue culture Petri dishes covered by reconstituted MDM in 4506 medium. RNA was purified from ~400,000 cells grown on 6 cm Petri dishes (~90% of confluence), using the Direct-Zol RNA MiniPrep kit (Zymo Research), according to manufacturer's protocol. RNA libraries were prepared in batches of 24-48 samples with approximately equal numbers of cases and controls with TruSeq Stranded Total RNA LT Library preparation kits with Ribo-Zero Gold (Illumina) according to manufacturer's protocol, using a Hamilton STARlet liquid handling robot to increase library preparation consistency. Equimolar pools of at least 4 libraries, containing both cases and controls, were constructed after quantification using the KAPA Library Quantification Kit (Kapa Biosystems), and sequenced together using HiSeq2000 DNA Sequencers (Illumina) with 100 bp single-end reads. On average, each sample was run in 3.93 lanes across 3.91 flow cells, to reduce potential channel and flow cell bias.
Mapping and assignment of reads to genes
We performed pre-mapping QC, read trimming, mapping and assignment to the sense strand of gene models (GenCode v22, max mismatch=6) using (https://genomics.isi.edu/gtfar) (see Supplemental Materials for detail). The number of uniquely mapped reads uniquely assigned to each gene model was used as a proxy of gene expression in DEX gene analysis.
RT-qPCR
Reverse transcription quantitative Polymerase Chain Reaction (RT-qPCR) was performed in duplicates using the Biomark HD (Fluidigm) on a Flex Six Gene Expression IFC (Integrated Fluidic Circuit), according to manufacturer's protocols and using the recommended reagents. Normalized relative expression (to ACTB) was calculated using the Δ Δ C t method (13), and log-transformed expression values were analyzed by ANOVA controlling for sex.
Differential gene expression analysis
We performed main differential gene expression (DEX) analysis between SCZ and controls using DESeq2 v1. 16.1 (14) in R v3.4.1, an algorithm assessing difference between mean gene expression in groups using a generalized linear model and assuming a negative binomial distribution of RNA-Seq reads. The analysis used covariates of sex, age, 4 library batches and 1 surrogate variable (SVA v3.24.4) . Procedures used to arrive at this covariate set are further described in Supplemental Materials. DESeq2's built-in normalization process was used.
The analysis was done on 23,920 expressed genes, defined as having on average at least 3.5 reads per sample, based on the density plot of log-transformed baseMean for all genes (Supplemental Figure S2 ). Resulting p-values were adjusted for multiple comparisons based on the Benjamini-Hochberg False Discovery Rate (FDR) using the p.adjust function in R.
Transcripts Per Million transcripts (TPM) values were calculated by dividing the mean number of unnormalized reads uniquely mapped to a gene by the median transcript length (15) in Gencode 22 for that gene and normalizing the resulting values so they sum to one million (16) .
Hierarchical clustering analysis was done in R using the 'hclust' function where the distance is calculated as one minus the Pearson correlation coefficient and using average linkage.
Permutation analysis
To test that our findings are not due to random variation we performed two forms of permutation analysis. First, 1,000 analyses were run under the same conditions as the main analysis, except with labels for diagnosis randomly permuted for all samples. Second, 250 analyses each of random subsets in 4 different configurations were analyzed: random half of cases vs. other half of cases, and random half of controls vs. other half of controls (null comparisons); and, due to the difference in number of cases and controls, random half of cases vs. random same number of controls, and random half of controls vs. random same number of cases (case/control comparisons). The numbers of differentially expressed (DEX) genes in the permuted analyses were compared to the number seen in the original, unpermuted analysis by Wilcoxon test. The number of DEX genes in the null comparisons was compared to the number DEX in the case/control comparisons by Mann-Whitney test.
GWAS enrichment analysis
We identified GWAS variants' p-values within a given gene based on the PGC SCZ2 dataset (https://www.med.unc.edu/pgc/results-and-downloads) and Gencode 22 annotation back-ported to human reference genome GRCh37 (hg19) to match coordinates used in GWAS.
Fisher's Exact Test was used to test for enrichment of genes co-localized with genome-wide significant (p<5x10 -8 ) GWAS peaks and calculate estimated odds-ratio. Due to a very broad peak in the HLA region (25 -34 Mb of chromosome 6 in GRCh37 coordinates), genes from this region were removed from the analysis, as were genes from the Y chromosome.
WGCNA
Weighted Gene Correlation Network Analysis (WGCNA) (17) was performed for all expressed genes on residuals after correction for effects of three explicit batches as well as one surrogate variable, with a soft-threshold power of 5 to achieve approximate scale-free topology (SFT R 2 >0.85; truncated R 2 >0.95), and a minimum module size of 50 genes. Modules of coexpressed genes produced by the algorithm were tested for enrichment of DEX genes by Fisher's exact test and for correlation of the eigengene with diagnosis (SCZ vs. control), after controlling for sex and age (linear model, no interactions); the p-value cutoff was adjusted for multiple comparisons. Gene set enrichment analysis was applied to modules that had a significant p-value on the aforementioned statistical tests.
Results
We collected samples of olfactory neuroepithelium and established CNON cell lines from 144 individuals with DSM-IV SCZ and 111 CTL ( Supplemental Table S1 ) (9,12). Strand-specific RNA-Seq of total RNA was performed, resulting in an average of 23.38 million (7.1 -106.7 million) uniquely mapped reads per sample, after exclusion of rRNA and mitochondrial genes.
DESeq2 was used to normalize the read counts assigned to expressed genes and perform differential gene expression analysis.
Characterization of CNON cells.
The RNA-Seq data in this study are consistent with our previous observations using Affymetrix Human Exon 1.0 ST arrays (9) that CNON lines are neural progenitors ( Supplemental table S2 ). In order to determine the period of human brain development the CNON lines most resemble, we compared RNA-Seq data from CNON to 647 poly-A RNA-Seq 76 bp datasets from post-mortem human brain samples across 41 individuals, 26 brain regions and 10 developmental stages (from "Early Fetal" to "Middle Adulthood") (www.brainspan.org, (18)). To mitigate the differences in RNA-Seq methodology, we transformed the gene expression values of each CNON sample using the coordinates described by the principal components of the BrainSpan data. The first principle component of the BrainSpan data roughly corresponds to developmental age and separates the pre-and post-natal samples (Supplemental Figure S3 ). The CNON samples form a tight cluster within the prenatal samples, particularly those from the mid fetal period (weeks 13-24, second trimester).
Genes differentially expressed in neural progenitor cells in SCZ
Using our analysis model (see Supplemental Materials for details), 80 genes were DEX between SCZ and CTL at a false discovery rate (FDR) of 10%, corresponding to a maximum pvalue of 3.3x10 -4 (Table 1 ; complete gene list in Supplemental Table S3 ). The average fold change was 1.8 (range 1.08 to 9.09) ( Figure 1 ) at expression levels of 0.07 to 552 TPM. E  N  S  G  0  0  0  0  0  1  6  4  5  3  2   T  B  X  2  0   p  r  o  t  e  i  n  _  c  o  d  i  n  g  0  .  1  1  5  -1  .  5  0  9  5  .  7  7  x  1  0   -0  3   E  N  S  G  0  0  0  0  0  1  3  5  9  1  4   H  T  R  2  B   p  r  o  t  e  i  n  _  c  o  d  i  n  g  2  .  7  4  1  .  1  6  9  5  .  7  7  x  1  0   -0  3   E  N  S  G  0  0  0  0  0  0  0  8  5  1  7   I  L  3  2   p  r  o  t  e  i  n  _  c  o  d  i  n  g  2  .  3  3  1  .  0  4  4  5  .  7  7  x  1  0   -0  3   E  N  S  G  0  0  0  0  0  1  6  5  1  9  7   V  E  G  F  D   p  r  o  t  e  i  n  _  c  o  d  i  n  g  0  .  6  1  4  1  .  1  2  5  6  .  6  6 x 1 0 To evaluate the accuracy of RNA-Seq gene quantification and DEX analysis, we compared results with RT-qPCR. For that purpose, we used a subset of 146 samples and performed DEX analysis on RNA-Seq data on only these samples. From this list of DEX genes we selected 5 genes (CCL8, HTR2B, PLAT, PPARGC1A, and VAV3) to include genes with fold change differences in both directions and spanning a range of gene expression levels.
Expression of these genes and ACTB (used for normalization) was assessed by RT-qPCR on the same set of 146 samples. Expression data from RT-qPCR and RNA-Seq were highly correlated within each gene (mean r=0.75, range 0.63 -0.90, all p-values <2x10 -15 ) (Supplemental Figure S4A -E), and mean expression of all six genes had correlation r=0.943 (p=0.0047) (Supplemental Figure S4F ). DEX of 4 of 5 genes was replicated, while one gene (PLAT) did not reach significance (p=0.15) but shows a trend in the same direction as that seen in RNA-Seq (Supplemental Figure S4GH ).
Permutation analysis of differential expression
To assess the probability that DEX findings could be due to random statistical variation, we performed two forms of permutation analysis. In the first, we randomly permuted the diagnosis labels, but held all other factors constant. We found a median of 11 differentially expressed genes at FDR<10%, which is significantly lower ( Figure S5 and Supplemental Materials). These permutation analyses strongly suggest that the majority of genes found to be DEX are not likely to be false positives.
GWAS enrichment analysis
It is thought that causal variants in SCZ GWAS loci regulate expression of genes involved in the etiology of SCZ (20, 21) . Previous studies have shown that regulatory variants are likely to be localized near to or within the genes they directly regulate (22), we tested the hypothesis that DEX genes are more likely to be co-localized with genome-wide significant (p<5x10 -8 ) variants from the PGC SCZ2 GWAS (19), excluding the HLA region of chromosome 6. Three DEX genes (ESAM, FOXO3, and SRPK2) were found to overlap independent genomewide significant variants (Fisher's exact test, odds-ratio=3.8, p=0.049) (Supplemental Figure   S6 ). Two other genes just missed being overlapped with genome-wide significant peaks. DEX gene IL1RAPL1 is almost genome-wide significant (p=5.3x10 -8 ), and AC007618.3 sits within an intron of CACNA1C, in which another intron contains one of the most significant GWAS signals (19) . For comparison, genes that were DEX (FDR<10%) based on either sex or age were not found to be enriched for overlap with SCZ GWAS variants (p>0.05).
The index SNP of another GWAS-significant locus (rs56972983, chromosome 5) is an eQTL for PCDHB16, in GTEx v7 (aorta). Three other DEX protocadherin genes, PCDHB10, PCDHB2 and PCDHB3, also have eQTLs within a broader region of this GWAS peak. It is noteworthy that all 48 protocadherin genes transcribed in CNON from the alpha, beta and gamma clusters, are expressed at a higher level in SCZ.
Gene set enrichment, pathway and network analyses of DEX genes
Gene set enrichment analysis (GSEA) shows significant (corrected p<0.05) enrichment of the DEX genes in 47 GO terms from 10 categories (related groups of terms) ( Table 2 , Supplemental Table S4) 
WNT5A, GAS1, and FOXO3. Based on GSEA, this module shows extremely significant enrichment for GO terms "cell cycle process", "chromosome segregation", and "DNA replication"
(corrected p<5x10 -18 for all), among others. Additionally, the module eigengene showed a significant correlation with SCZ status (p=0.004).
Hierarchical clustering of samples based on the expression of genes in WGCNA module #3 shows a clear separation into two groups, an effect further supported by examination of the heatmap ( Figure 4A ). The same separation is apparent when SCZ and CTL samples are examined separately ( Figure 4BC ). The smaller subgroup shows an enrichment of SCZ 
Convergence with other genetic studies
Although SCZ GWAS is considered the most general and direct way to identify causative common genetic variants, consideration of other related phenotypes, and other types of genetic studies, such as de novo mutations, mutations segregating with psychiatric disorders in multigeneration families, and gene expression studies in relevant models also provide information about genes likely involved in SCZ. We found that many genes identified in these studies are also DEX in our study. FOXO3, SRPK2, BACE2, GABRA4, RC3H1, NRXN3, TANC2 and LYL1 are genome-wide significant in DEPICT-based association in GWAS metaanalysis of intelligence and associated traits (33). SNP within PRKCA is significant in GWAS of neuroticisms (34). Four DEX genes have been reported to have de novo non-silent mutations in individuals with SCZ (PI15, TANC2 -(35), ESAM, SSBP3 -(36)), four have been reported to have de novo missense mutation(s) in patients with autism spectrum disorder (MCAM, PRKCA -0 (37), FLG (38), PCDHB16 (39)), copy number variations of IL1RAPL1 have been identified in multiple patients with SCZ (40) and multiple mutations in the same gene have been observed in individuals with autism spectrum disorders and intellectual disability (reviewed in (41)). An exonic deletion in NRXN3 was found to segregate with neurodevelopmental and neuropsychiatric conditions in a three-generation Chinese family (42). Moreover, among 19 genes most correlated with WNT5A (R>0.6) nine have de novo mutations in either SCZ, autism spectrum disorder or developmental disorder, demonstrating striking convergence between gene expression data and de novo mutation studies of SCZ on a pathway level. In total, 18 of the 80 genes overlap with previously published results from genome-wide studies of psychiatric disorders, and some of them have supported evidence from several independent studies (ESAM, FOXO3, SRPK2, IL1RAPL1, TANC2, PRKCA, NRXN3).
The largest transcriptome study of SCZ was performed by the CommonMind Consortium (CMC) using post-mortem adult dorsolateral prefrontal cortex (258 SCZ vs. 279 CTL) (43), which has a very different pattern of gene expression than CNON or the fetal brain (Supplemental Figure S3, and (18) ). Only two genes showed significant differences after correcting for multiple comparisons in both studies (FAM110C and CLEC3B) and the differences were in opposite directions in both cases. However, correlation of test statistics for genes expressed in both studies was highly significant (r=0.174; p<2.2x10 -16 , n=14924 genes);
this correlation increased to r=0.42 (p<2.2x10 -16 , n=453 genes) on the set of genes that were nominally significant in both studies.
We also compared our results with data from studies of iPSC-derived neural progenitor cells, which are most similar to the first trimester samples in BrainSpan (44). We found three DEX genes, all changed in the same direction, in common with a study based on microarray expression profiling of 4 SCZ and 4 CTL individuals (ARHGAP26, NRXN3, LRRC61) (44), and there was a significant positive correlation in z statistics testing for differential expression between SCZ and CTL groups for genes with publicly available data (Pearson's r=0.117, 1 p=0.025, n=367 genes). This work was extended using RNA-Seq and two additional controls (4SCZ/6CTL) (45) and shared 5 genes with our DEX list (GAS1, WNT5A, BACE2, FRMD6, PRKCA); all genes except PRKCA, had the same direction of effect. As before, the overall comparison of test statistics with our study was significant (r=0.15, p=4.26x10 -5 , n=724 genes).
This latter study implicated Wnt signaling in schizophrenia, which agrees with our findings of involvement of WNT5A in etiology of the disease.
However, the largest SCZ study using iPSC-derived NPCs (10SCZ/9CTL) from the same group is significantly negative correlated in test statistics with our data for all genes (r=-0.08, p<2.2x10 -16 , n=15,862). The results of this latest study are also significantly negatively correlated with two previous studies from the same group (r=-0.33, p=7.87x10 -12 , n=412 with microarray study and r=-0.19, p=1.13x10 -6 , n=654 with RNA-seq study).
Discussion
Schizophrenia is a complex genetic disorder that originates during fetal development, typically manifests symptoms in adolescence and early adulthood, and persists throughout adult life. While post-mortem brain transcriptome studies assess changes in gene expression of differentiated neuronal and glial cells in the adult brain, we developed a genetically unmodified cell-based system, CNON, to study the neurodevelopmental component of the disorder. These cells, developed from olfactory neuroepithelium, are neural progenitors, and express a transcriptome most similar to the mid-fetal period of the brain (Supplemental Figure S3 ), a time of increased risk for the development of schizophrenia (46,47). We examined differences in mean gene expression between SCZ and CTL groups, but other approaches for finding biologically important differences are also possible (48). We identified 80 DEX genes at FDR<10% and found an overrepresentation of genes annotated with gene ontology terms related to processes of cell proliferation, migration and differentiation, all fundamental aspects of neurodevelopment.
We looked for convergence of our transcriptome data analysis with results of other types of genomic or transcriptomic studies of SCZ or related psychiatric diseases that were performed on a comprehensive, genome-wide or transcriptome-wide basis. GWAS is considered the most general way to identify causative genomic loci associated with common variants. The main mechanistic explanation for involvement of GWAS loci in disease etiology is through altering gene expression (20,21). However, the specific causal SNPs are generally not known, and neither are the genes which they regulate, or the developmental stage or type of cells where the regulation is important for the development of the disease. Despite these complexities, our study shows a significant agreement between our DEX gene list and genome-wide significant loci in the PGC SCZ2 GWAS (odds-ratio=3.8, p=0.049). Other genomic approaches, such as identification of de novo non-synonymous mutations in psychiatric disorders, also provide independent evidence for involvement of some DEX genes with SCZ or neurodevelopment in general, suggesting that alterations in expression of some genes and changes in gene function could result in similar phenotype. Finally, a transcriptome study (45) (53). These studies and our results agree that Wnt signaling is enhanced in SCZ.
In CNON lines, WNT5A has the highest expression of Wnt ligand genes (TPM=185.5) and is DEX (FDR=1.9%, SCZ>CTL). Transcription of WNT5A is regulated by a JAK-STAT3 signaling pathway, which includes DEX genes JAK1 (FDR=3%, SCZ>CTL) and Leptin (LEP, FDR=9.9%, SCZ>CTL) ( Figure 3A ) (25). Additionally, IL-32 (FDR=0.58%, SCZ>CTL) has been shown to increase the expression of IL-6, another JAK-STAT3 ligand (26), and may increase WNT5A through IL-6 or via STAT3. Lastly, PI15 (FDR=0.059, SCZ>CTL), has been shown to induce WNT5A (55). We also observe two DEX genes in the downstream canonical signaling pathway of WNT5A; PGC1-alpha (FDR=4.5%, SCZ>CTL) and FOXO3 (FDR=3.5%, SCZ>CTL), the latter is a product of one of the three DEX genes that lies under a PGC SCZ2 GWAS peak ( Figure 3B ), providing convergence between the results of the two types of studies at the level of signaling pathways. WNT5a is also involved in multiple interrelated non-canonical Wnt signaling pathways. There are two DEX genes whose products are involved in non-canonical 
